Medscape November 3, 2025
Diabetes technology has ushered in a new era that allows patients to make necessary changes to achieve blood sugar control while simultaneously providing real-time data to clinicians. Yet, clinical practice has continued to lag behind; primary care uptake has been inconsistent, and only 50% of patients with diabetes reportedly achieve glucose control.
The American Diabetes Association currently recommends that doctors offer continuous glucose monitors (CGMs) to patients with type 1 or type 2 diabetes who are using insulin. CGMs provide real-time blood sugar measurements every 5 minutes, alert users to peaks and lows, and facilitate the ability to learn factors that influence glucose, not to mention track trends over time. Use of CGMs have been shown to provide significantly better...
Today's Sponsors
Today's Sponsor